Skip to content
Datasets/OHSU-CNL

Philadelphia-Negative Neutrophilic Leukemias (CNL/aCML/MDS/MPNu)

Underused opportunityMixedMachine-extracted
OHSUAvailable from GDC

Can it answer your research question?

1 of 6 supported
  • Overall survival

    Supported

    Vital status and time are populated; median follow-up 1.6 years; 118 cases with follow-up; endpoint: overall survival.API

  • Progression or recurrence

    Not supported

    progression_or_recurrence is informative for no case in the harmonized records.API

  • Treatment response

    Not supported

    treatment_outcome is populated for no case in the harmonized records.API

  • Which drug was given

    Not supported

    therapeutic_agents is recorded for no case in the harmonized records.API

  • Stage-adjusted modelling

    Not supported

    ajcc_pathologic_stage is informative for no case in the harmonized records.API

  • Analysis by race or ethnicity

    Not supported

    Race is informative for no case in the harmonized records.API

Judged from the repository’s own field completeness (thresholds). “Not measured” means we have not probed that field for this record, not that the data lack it.

At a glance

Every percentage is the repository’s own record of what is filled in
CasesAPI
176
Measurement types
3
1,628 files, 4.1 TB
Follow-upAPI
19.1 months
for 118 of 176 cases; overall survival
Treatment responseAPI
Not recorded

SubjectCALC

Myeloid

As filed by the repository

Chronic Myeloproliferative DisordersHematopoietic and reticuloendothelial systems

Who is in the cohortAPI

A usable value“Not reported” or “unknown”No value recorded
  • Sex74 male · 39 female · 63 unknown
  • Race176 not reported
  • Ethnicity176 not reported
  • Vital status54 dead · 8 alive · 65 unknown · 49 not reported

Age at diagnosis

Median 70, middle half 59–76, range 27–90 years across 126 cases.

What was measured, and on how many

3 measurement types, none covering the whole cohort.

  • Whole exome sequencing158 of 176 · 90%
  • Bulk RNA sequencing80 of 176 · 45%
  • Structural Variation80 of 176 · 45%
Platform, files and data levels
AssayPlatformFilesLevels
Whole exome sequencingAPIillumina908-
Bulk RNA sequencingAPIillumina720-
Structural VariationAPI-320-
How complete all 29 clinical fields are - 1 informative for at least 80% of cases

A field counts as informative only when it holds a real value. “Not reported” blocks an analysis just as a missing field does. Fields marked 1:n can hold several records per case, so they show the share of cases with any record.

Informative - a usable valuePresent but uninformative - “not reported” or “unknown”Absent - no value recorded

Outcome

  • Vital statusAPI35%
  • Cause of deathAPI0%
  • Progression or recurrenceAPI0%
  • Last known disease statusAPI0%

Follow-up

  • Disease response at follow-upAPI0%
  • Progression at follow-upAPI0%
  • ECOG performance statusAPI0%

Treatment

  • Prior treatmentAPI0%
  • Treatment typeAPI0%
  • Treatment givenAPI0%
  • Therapeutic agentsAPI0%
  • Treatment outcomeAPI0%
  • Regimen or line of therapyAPI0%

Staging

  • AJCC pathologic stageAPI0%
  • AJCC clinical stageAPI0%

Diagnosis

  • Tissue or organ of originAPI100%
  • Primary diagnosisAPI71%
  • Prior malignancyAPI0%
  • Synchronous malignancyAPI0%

Pathology

  • Morphology (ICD-O)API71%
  • Tumor gradeAPI0%
  • Classification of tumorAPI0%

Demographics

  • Sex at birthAPI64%
  • RaceAPI0%
  • EthnicityAPI0%
  • Population groupAPI0%
  • Country of residenceAPI0%

Exposure

  • Tobacco smoking statusAPI0%
  • Alcohol historyAPI0%

Access

MixedSome components are open; others need approval.

Data Access Request through dbGaP using an eRA Commons account; institutional signing official approval required

Open components
80 open-access files
Controlled components
1,548 controlled-access files
Typical turnaround
days to a few weeks after signing official approval
License
NIH Genomic Data Sharing Policy terms
Citation requirement
Cite the dataset accession and the program's publication guidelines; see the GDC publication policy.

What it is good for

Written and checked by a reviewer, not generated from metadata.

No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.

What it cannot tell you

Written by a reviewer against the source, not inferred from what is missing.

No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.

Who has used it

Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.

Analyzed the dataCALC2
1
accession in the methods section
Declared using it
1
named in a data availability statement
Cited the paper
-
attention to the publication, not reuse of the data
Against expectation
Well below
about 8 articles expected; index -2.15

What articles did with it

Only the last row counts as reuse. Where the accession appears in an article tells us what the authors did with the data.

  • Mentioned the dataset0
  • Accession found in text0
  • Declared using it1
  • Analyzed the data1

Against comparable datasets

1 article analyzed these data. About 8 would be expected. The expectation comes from a model of size, age, breadth and access tier.

  • Analyzed it1
  • Expected~8
More articles are listed below than the count
The headline count is deliberately narrow: one section of one accession (METHODS:"phs001799"), so every dataset in the corpus is counted the same way and the numbers can be compared. The 4 articles listed below were retrieved and graded one at a time, and an article counts as having analyzed the data wherever the accession sits in the analysis - methods, results, tables, figures or supplement - under any of this dataset’s accessions. Read the list as the evidence about these articles, and the count as the number that is comparable across datasets.
Why this is an underused opportunity
  • 1 article(s) reference this dataset's accession in a methods section, against 7.9 predicted for datasets of comparable size, age, modality breadth and access tier (reuse gap index -2.15 on a log2 scale, 8th percentile of the assessed corpus).

Compared against 132 datasets in this corpus with a citable accession and sufficient metadata. See Methods for the model.

Articles that analyzed the data

Each was retrieved and graded individually.

Deep-review sample: author overlap and funding were checked only for the 4 articles listed here, not for every article examined. Of the 4 that analyzed the data, author overlap with the generating team could not be checked for any of them, and 1 of the 4 we could check were themselves NCI-funded. These are sample counts, not population estimates.

Community examples

Share your example

Analyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.

Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.

Start here

Starter code generated from this record’s own identifiers, then the access steps.

Get the data in code

GDC: list open files and download thempython

Open-access files need no account. Controlled files need an approved dbGaP request and a token passed to gdc-client.

import json, requests

PROJECT = "OHSU-CNL"
filters = {"op": "and", "content": [
    {"op": "in", "content": {"field": "cases.project.project_id", "value": [PROJECT]}},
    {"op": "in", "content": {"field": "access", "value": ["open"]}},
]}
params = {"filters": json.dumps(filters),
          "fields": "file_id,file_name,data_category,data_type,file_size",
          "size": "10000", "format": "JSON"}
files = requests.get("https://api.gdc.cancer.gov/files", params=params, timeout=60).json()["data"]["hits"]
print(len(files), "open files")

# Write a manifest and fetch with the GDC client (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool)
with open("manifest.txt", "w") as fh:
    fh.write("id\n" + "\n".join(f["file_id"] for f in files))
# $ gdc-client download -m manifest.txt
GDC: clinical table for every casepython
import json, requests

filters = {"op": "in", "content": {"field": "project.project_id", "value": ["OHSU-CNL"]}}
params = {"filters": json.dumps(filters), "size": "5000", "format": "TSV",
          "fields": ",".join([
              "submitter_id", "demographic.vital_status", "demographic.days_to_death",
              "diagnoses.days_to_last_follow_up", "diagnoses.ajcc_pathologic_stage",
              "diagnoses.treatments.treatment_type", "diagnoses.treatments.treatment_outcome"])}
tsv = requests.get("https://api.gdc.cancer.gov/cases", params=params, timeout=60).text
open("OHSU-CNL_clinical.tsv", "w").write(tsv)
This page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/gdc-ohsu-cnl.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
    print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'

Access steps

  1. 1
    Open the project in the GDC Data PortalFor people5 minutes

    Check the portal's current case and file counts before requesting anything; the cohort can change after this record was built.

    https://portal.gdc.cancer.gov/projects/OHSU-CNL

    Generated from repository policy. Check the linked policy before downloading.

  2. 2
    Download the open files without an accountFor peopleminutes to hours, by cohort size

    80 open-access files are marked open access. Add them to a portal cart, export a manifest, and fetch it with the GDC Data Transfer Tool.

    gdc-client download -m gdc_manifest.txt
    https://gdc.cancer.gov/access-data/gdc-data-transfer-tool

    Generated from repository policy. Check the linked policy before downloading.

  3. 3
    Request controlled access through dbGaPFor peopledays to a few weeks after signing official approval

    1,548 controlled-access files require an approved data access request. The request starts at dbGaP, not in the portal. The relevant study is phs001799.

    Requires: eRA Commons account, institutional signing official approval, dbGaP data access request for phs001799

    https://gdc.cancer.gov/access-data/obtaining-access-controlled-data

    Generated from repository policy. Check the linked policy before downloading.

  4. 4
    Download controlled files with your tokenFor people

    An approved request yields a token. The same manifest fetches nothing controlled without it.

    Requires: approved dbGaP request, GDC authentication token

    gdc-client download -m gdc_manifest.txt -t gdc-user-token.txt
    https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001799

    Generated from repository policy. Check the linked policy before downloading.

  5. 5
    Query the project from code, with no credentialsFor agents

    The file index is public even where files are not, so an agent can size the cohort before anyone requests access.

    curl -s 'https://api.gdc.cancer.gov/files' --get \
      --data-urlencode 'filters={"op":"in","content":{"field":"cases.project.project_id","value":["OHSU-CNL"]}}' \
      --data-urlencode 'fields=file_id,file_name,data_type' \
      --data-urlencode 'size=10000' --data-urlencode 'format=TSV'
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

  6. 6
    Pass the token when the agent needs controlled filesFor agents

    Without a token, an API query may return only the open subset. Compare returned counts with the record before treating them as the whole cohort.

    Requires: GDC authentication token

    curl -H "X-Auth-Token: $GDC_TOKEN" https://api.gdc.cancer.gov/data/<file_id>
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

Provenance

All of it, and more, is in this record’s JSON.

Identifiers

Versions and verification

Released
1 Jan 2019
Metadata retrieved
18 Sept 2026
Review status
Machine-extracted
Data generation funding
Funded data generation

Funding

Awards resolved through NIH RePORTER. Awards that paid to generate these data are listed apart from awards that paid to reuse them. Both are returns on NCI investment, but different ones.

Funded reuse of these data

  • R01CA183974Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven CancerJeffrey Wallace TynerFY2014-2018API
  • R00CA237630Characterizing the pathogenesis and targeted therapeutics of Wilms' Tumor 1 (WT1) mutations in AMLHaijiao ZhangFY2021-2023API
  • R00CA190605Pathogenic Mechanisms of CSF3R Mutations in LeukemiaJulia E MaxsonFY2016-2018API
  • R00CA151457ROR1 as a Therapeutic Target in Acute Lymphoblastic LeukemiaJeffrey Wallace TynerFY2012-2014API
  • K99CA237630Characterizing the pathogenesis and targeted therapeutics of Wilms' Tumor 1 (WT1) mutations in AMLHaijiao ZhangFY2019-2020API
  • K99CA190605Pathogenic Mechanisms of CSF3R Mutations in LeukemiaJulia E MaxsonFY2014-2015API

Funded infrastructure or harmonization

  • U54CA224019Architecture and Trajectory of Acquired Resistance to Therapy in AMLBRIAN J DRUKER, Shannon K. McWeeneyFY2017-2026API
  • U01CA217862Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic MalignanciesBRIAN J DRUKER, Jeffrey Wallace TynerFY2017-2021API
  • P30CA069533Cancer Center AdministrationMindy Roberts, Jeffrey Wallace TynerFY1997-2026API
  • P01CA066996Development of Novel Therapeutic Strategies in Human LeukemiasSCOTT A ARMSTRONG, DANIEL J DEANGELOFY1996-2026API

For softwarerecord JSON